HIV 1 News and Research

RSS

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

Gilead Sciences, Inc. today announced that a Phase II clinical trial of its investigational integrase inhibitor-based, once-daily, fixed-dose “Quad” regimen of elvitegravir, GS 9350 and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV-1 infection met its primary objective.

7 Jan 2010

U.N. leaders, HIV advocates laud official end to HIV travel ban

A travel ban in place since 1987 that prevented non-U.S. citizens with HIV/AIDS from entering the country officially ended Monday, The Hill's "Blog Briefing Room" reports (Romm, 1/4).

6 Jan 2010

Medicare begins to reimburse for HIV screening

The Hartford Courant reports that "testing for the virus among those 65 and older lags far behind testing of other Americans, and experts say they worry that HIV cases in older adults go undiagnosed — some because of the stigma that the disease still carries, some because patients might dismiss the symptoms of the virus as signs of other conditions more frequently associated with aging and some because doctors can be hesitant to talk to older patients about sex or link their symptoms with HIV."

6 Jan 2010

Clinton foundation releases donor list

Former president Bill Clinton on Friday released a list of the donors who have given money to his foundation "under an agreement with President Obama to prevent the appearance of conflicts with Hillary Rodham Clinton's role as secretary of state," the Washington Post reports.

6 Jan 2010

Also in global health news: Aid in S. Somalia; virus-resistant mosquitoes; composting toilets in Haiti; U.S. Congressional Group visits India

The U.N. World Food Program (WFP) announced Tuesday that it has been forced to halt "aid distribution to about 1 million people in southern Somalia because of attacks against staff and demands by armed groups that aid groups remove women from their teams," the Associated Press reports.

5 Jan 2010

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

Circumcision, which substantially lowers HIV risk in men, also dramatically changes the bacterial communities of the penis, according to a study led by scientists at the Translational Genomics Research Institute (TGen) and Johns Hopkins University and published Jan. 6 in the scientific journal PLoS ONE.

5 Jan 2010

AHF launches second HIV Testing Tour across the US

In an effort to raise local and national awareness about the importance—and ease—of HIV testing and to challenge attitudes about moving toward a streamlined model of HIV testing and counseling nationwide, AIDS Healthcare Foundation (AHF) is proud to report its launch of a second HIV Testing Tour across the US after its successful completion of its recent and ambitious 14 city AHF Magic Johnson HIV Testing Caravan in mid-2009.

5 Jan 2010

$HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture$

HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures.

5 Jan 2010

Annelie Wendeberg presents protocol for identification of environmental microbes

Metagenomics, the study of DNA isolated from samples of naturally occurring microbial populations, is rapidly growing. Improvements to cloning and sequencing techniques are allowing researchers to study microorganisms in environmental samples, and new knowledge of species interactions and community dynamics is emerging.

5 Jan 2010

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

5 Jan 2010

Study examines relationship between parental vaccine refusal and risk of varicella infection in children

Children of parents who refuse vaccines are nine times more likely to get chickenpox compared to fully immunized children, according to a new study led by a vaccine research team at Kaiser Permanente Colorado's Institute for Health Research.

5 Jan 2010

NPR examines future of U.S. global AIDS strategy

NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.

5 Jan 2010

AP series examines worldwide impact of drug resistance

The Associated Press reports on how the misuse of drugs worldwide has contributed to drug-resistant diseases in a series of articles following a six-month investigation by the news service.

5 Jan 2010

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.

5 Jan 2010

Independent examines diseases that jump from animals to humans

The Independent examines the expansion of human diseases that originated in animals. "At least 45 diseases that have passed from animals to humans have been reported to U.N. agencies in the last two decades, with the number expected to escalate in the coming years," the Independent writes.

5 Jan 2010

CDC aims for improved efficiency, increased support of science

Changes "aimed at increasing the agency's efficiency and making it more user-friendly" include combining "the work of the malaria branch, the epidemiology program and HIV/AIDS efforts" under the newly formed Center for Global Health, the Atlanta Journal-Constitution reports (Poole, 1/1).

4 Jan 2010

Sharing Miracles: A TV program that features inspirational stories of real patients

Major League Baseball slugger Aaron Boone will be featured on January's episode of Sharing Miracles - a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs every week on more than 300 television stations nationwide.

31 Dec 2009

U.S. Congress designates January as ‘Cervical Health Awareness Month’

Nearly 4,000 women in America will die this year from cervical cancer. These cancers are, largely, preventable, and raising public awareness can save lives. It's why the U.S. Congress has designated January as Cervical Health Awareness Month.

31 Dec 2009

Senate health care bill will increase patient access and help create high-wage, high-value jobs

“These provisions mean increased access for the patients of today and renewed hope for the patients of tomorrow. In addition, they will help create high-wage, high-value jobs in our nation’s burgeoning biotech sector and help maintain U.S. global leadership in innovation.”

28 Dec 2009

Also in Global Health news: Food shortages in Eritrea; Kenya HIV testing; aid in Malawi, Nepal; U.S. agriculture appointment

BBC examines Eritrea's decision to pass on international food aid in an effort to produce enough food for its population. According to Girma Asmerom, Eritrea's ambassador to the EU, "foreign food aid demonises the local people and makes them lazy." The government's strategy for addressing food shortages, includes distributing food from some areas in the country that had a bumper harvest, he said.

28 Dec 2009

HIV 1 News and Research

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

U.N. leaders, HIV advocates laud official end to HIV travel ban

Medicare begins to reimburse for HIV screening

Clinton foundation releases donor list

Also in global health news: Aid in S. Somalia; virus-resistant mosquitoes; composting toilets in Haiti; U.S. Congressional Group visits India

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

AHF launches second HIV Testing Tour across the US

HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture

Annelie Wendeberg presents protocol for identification of environmental microbes

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Study examines relationship between parental vaccine refusal and risk of varicella infection in children

NPR examines future of U.S. global AIDS strategy

AP series examines worldwide impact of drug resistance

GIVI scientists discover anti-HIV molecule that enhances infection, reduces transmission

Independent examines diseases that jump from animals to humans

CDC aims for improved efficiency, increased support of science

Sharing Miracles: A TV program that features inspirational stories of real patients

U.S. Congress designates January as ‘Cervical Health Awareness Month’

Senate health care bill will increase patient access and help create high-wage, high-value jobs

Also in Global Health news: Food shortages in Eritrea; Kenya HIV testing; aid in Malawi, Nepal; U.S. agriculture appointment

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News